United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 17, 2026 · Filed Jul 20, 2026

On Jul 17, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$537.05 for US$5.1M under a trading plan, leaving 324,443 shares. Filed Jul 20, 2026 (Form 4).

Sold
9,500 shares
Price
US$537.05 average (US$528.91 to US$542.43)
Value
US$5.1M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 17, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 17, 2026Common StockSale240US$528.91333,703Indirect
Jul 17, 2026Common StockSale240US$530.83333,463Indirect
Jul 17, 2026Common StockSale720US$534.57332,743Indirect
Jul 17, 2026Common StockSale2,350US$535.53330,393Indirect
Jul 17, 2026Common StockSale2,110US$536.36328,283Indirect
Jul 17, 2026Common StockSale1,160US$537.45327,123Indirect
Jul 17, 2026Common StockSale423US$538.70326,700Indirect
Jul 17, 2026Common StockSale821US$539.63325,879Indirect
Jul 17, 2026Common StockSale251US$540.69325,628Indirect
Jul 17, 2026Common StockSale892US$542.06324,736Indirect
Jul 17, 2026Common StockSale293US$542.43324,443Indirect

Source

View original at SEC

Related